Conferences Callio Therapeutics is attending in 2026–2027
Callio Therapeutics is listed at 2 conferences on Tnuki's calendar in 2026–2027: World ADC London 2027 (on the program) and World ADC San Diego 2026 (on the program). Callio Therapeutics is a clinical-stage biotech developing dual-payload ADCs, led by a HER2-targeted program, to counter tumor resistance. As of Oct 17, 2026.
| Conference | Details | Involvement | Tnuki guide |
|---|---|---|---|
17th World ADC LondonEurope’s antibody-drug conjugate developersOfficial site |
London, UK ~700 attendees | On the programNo booth or sponsorship in the organizer’s published lists Program 1 panel discussion Attendee mix: Mostly industry; European ADC discovery, analytical and process development leads, some academics
Attending
|
Open the guide Search and filter attendees |
17th World ADC San DiegoAntibody-drug conjugate developersOfficial site |
Past San Diego, CA ~1.3k attendees | On the programNo booth or sponsorship in the organizer’s published lists Program 3 talks, 2 panel discussions, 1 session chair Attendee mix: Almost entirely industry; ADC discovery, chemistry, analytical and bioprocess leads, two in three at director level or above
Attending
|
Open the guide Search and filter attendees |
We hold published exhibitor, sponsor, program or attendee lists for 54 of the 156 conferences on our calendar, so this page shows Callio Therapeutics’s involvement at those 54 only — it is not a complete record of where they go. Organizers typically publish a list around six months before the event, so coverage grows over time.
Instantly find decision makers at Callio Therapeutics
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!